Please assess the completion status of the following clinical trial:

Trial Title: Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients classified with RA according to the American College of Rheumatology (ACR) / European League Against Rheumatism (EULAR) 2010~* Patients treated in the outpatient service of the Rheumatology Service of the Hospital Civil de Guadalajara Dr. Juan I Menchaca.~* Sign an Informed Consent Letter~* Under treatment with conventional Disease-Modifying Antirheumatic Drugs (DMARDS)~Exclusion Criteria:~* Patients with a previous diagnosis of diabetes mellitus, systemic hypertension, thyroid, kidney or liver disease~* History of acute myocardial infarction, cardiac arrhythmias, cerebral vascular event or heart failure~* Smoking active patients in the last 6 months~* Patients with a desire for close conception, pregnant or breastfeeding.~* Patients with blood pressure \<90/60 mmHg~* Patients who do not accept to participate in the study~* Patients with a BMI greater than ≥40 Kg / m2~* Non-palpable carotid and femoral pulses~* Unstable psychological state

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Enalapril Maleate (Type: EXPERIMENTAL): Enalapril Maleate 5 mg every 12 hrs for 90 days.
- Placebo (Type: EXPERIMENTAL): Substance that lacks in itself therapeutic action.

Based on this trial design, predict the completion outcome and termination type (if applicable).